EyeMed Vision Care, one of the nation’s leading vision benefits companies and part of Luxottica (NYSE: LUX), a leader in vision care and eyewear, introduces a new Diabetic Eye Care benefit that provides follow-up care and supplementary diagnostic testing for patients with diabetes, a leading cause of adult blindness.
The EyeMed Diabetic Eye Care benefit allows patients with type 1 or type 2 diabetes to receive additional services from their eye care provider. Under this new benefit, patients can receive office service visits every six months to monitor for signs of diabetic complications.
In addition, diagnostic testing is covered by the EyeMed Diabetes Eye Care benefit every six months. This may include photodocumentation of diabetic retinal findings or laser scanning to detect the earliest stages of swelling of the retina.
“Diabetes can create complications throughout the body, and the eye is a key area that needs to be monitored closely, especially for those patients diagnosed with diabetes,” said John Lahr, O.D., FAAO, medical director at EyeMed Vision Care. “The eye is the only place in the body where blood vessels can be easily viewed and monitored without invasive procedures. Since diabetes is associated with changes to the small vessels in the body, eye complications associated with diabetes can serve as a warning that other organs in the body with small vessels may be at risk for diabetic complications.”EyeMed President Liz DiGiandomenico said the Diabetic Eye Care benefit is just one component of EyeMed’s larger vision wellness program and an important complement to an employer’s care management strategy. “The eye health and vision wellness of our membership is a priority at EyeMed, and we know it’s a priority for our clients. We consider regular, comprehensive eye exams to be as important as medical health screenings, a healthy diet and exercise. We’ll continue to invest in and roll out enhancements to our vision wellness program supporting the needs of our employers.”
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV